125 related articles for article (PubMed ID: 33132087)
1. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage.
Dopico-López A; Pérez-Mato M; da Silva-Candal A; Iglesias-Rey R; Rabinkov A; Bugallo-Casal A; Sobrino T; Mirelman D; Castillo J; Campos F
Transl Res; 2021 Apr; 230():68-81. PubMed ID: 33132087
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia.
Pérez-Mato M; Ramos-Cabrer P; Sobrino T; Blanco M; Ruban A; Mirelman D; Menendez P; Castillo J; Campos F
Cell Death Dis; 2014 Jan; 5(1):e992. PubMed ID: 24407245
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.
Campos F; Sobrino T; Ramos-Cabrer P; Argibay B; Agulla J; Pérez-Mato M; Rodríguez-González R; Brea D; Castillo J
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1378-86. PubMed ID: 21266983
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate.
Zlotnik A; Gruenbaum SE; Artru AA; Rozet I; Dubilet M; Tkachov S; Brotfain E; Klin Y; Shapira Y; Teichberg VI
J Neurosurg Anesthesiol; 2009 Jul; 21(3):235-41. PubMed ID: 19543002
[TBL] [Abstract][Full Text] [Related]
5. A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase 1 impairs pancreatic cancer growth.
Yoshida T; Yamasaki S; Kaneko O; Taoka N; Tomimoto Y; Namatame I; Yahata T; Kuromitsu S; Cantley LC; Lyssiotis CA
Biochem Biophys Res Commun; 2020 Feb; 522(3):633-638. PubMed ID: 31787239
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glutamate oxaloacetate transaminase 1 in cancer cell lines results in altered metabolism with increased dependency of glucose.
Zhou X; Curbo S; Li F; Krishnan S; Karlsson A
BMC Cancer; 2018 May; 18(1):559. PubMed ID: 29751795
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and preliminary crystallographic studies of human glutamate oxaloacetate transaminase 1 (GOT1).
Jiang X; Chang H; Zhou Y
Protein Expr Purif; 2015 Sep; 113():102-6. PubMed ID: 26003525
[TBL] [Abstract][Full Text] [Related]
8. Brain neuroprotection by scavenging blood glutamate.
Zlotnik A; Gurevich B; Tkachov S; Maoz I; Shapira Y; Teichberg VI
Exp Neurol; 2007 Jan; 203(1):213-20. PubMed ID: 17014847
[TBL] [Abstract][Full Text] [Related]
9. Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors.
Holt MC; Assar Z; Beheshti Zavareh R; Lin L; Anglin J; Mashadova O; Haldar D; Mullarky E; Kremer DM; Cantley LC; Kimmelman AC; Stein AJ; Lairson LL; Lyssiotis CA
Biochemistry; 2018 Nov; 57(47):6604-6614. PubMed ID: 30365304
[TBL] [Abstract][Full Text] [Related]
10. Glutamate-Oxaloacetate Transaminase 1 Impairs Glycolysis by Interacting with Pyruvate Carboxylase and Further Inhibits the Malignant Phenotypes of Glioblastoma Cells.
Tang T; Liu Y; Yang M; Tu M; Zhu W; Chen M
World Neurosurg; 2021 Oct; 154():e616-e626. PubMed ID: 34325031
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke.
Rink C; Gnyawali S; Peterson L; Khanna S
Antioxid Redox Signal; 2011 May; 14(10):1777-85. PubMed ID: 21361730
[TBL] [Abstract][Full Text] [Related]
12. Adapalene inhibits ovarian cancer ES-2 cells growth by targeting glutamic-oxaloacetic transaminase 1.
Wang Q; Zhang Q; Luan S; Yang K; Zheng M; Li K; Chen L; Li H
Bioorg Chem; 2019 Dec; 93():103315. PubMed ID: 31605927
[TBL] [Abstract][Full Text] [Related]
13. Effects of blood glutamate scavenging on cortical evoked potentials.
Nagy D; Knapp L; Marosi M; Farkas T; Kis Z; Vécsei L; Teichberg VI; Toldi J
Cell Mol Neurobiol; 2010 Oct; 30(7):1101-6. PubMed ID: 20607387
[TBL] [Abstract][Full Text] [Related]
14. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
Campos F; Sobrino T; Ramos-Cabrer P; Castillo J
Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
[TBL] [Abstract][Full Text] [Related]
15. The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay.
Wu Q; Sun Z; Chen Z; Liu J; Ding H; Luo C; Wang M; Du D
Bioorg Med Chem Lett; 2022 Oct; 73():128883. PubMed ID: 35820623
[TBL] [Abstract][Full Text] [Related]
16. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.
Campos F; Sobrino T; Ramos-Cabrer P; Castellanos M; Blanco M; Rodríguez-Yáñez M; Serena J; Leira R; Castillo J
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1387-93. PubMed ID: 21266984
[TBL] [Abstract][Full Text] [Related]
17. Discovery of GOT1 Inhibitors from a Marine-Derived
Yan S; Qi C; Song W; Xu Q; Gu L; Sun W; Zhang Y
Mar Drugs; 2021 Oct; 19(11):. PubMed ID: 34822459
[TBL] [Abstract][Full Text] [Related]
18. Glutamic oxaloacetic transaminase 1 as a potential target in human cancer.
Song Z; Yang Y; Wu Y; Zheng M; Sun D; Li H; Chen L
Eur J Pharmacol; 2022 Feb; 917():174754. PubMed ID: 35007521
[TBL] [Abstract][Full Text] [Related]
19. Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality.
da Silva-Candal A; Vieites-Prado A; Gutiérrez-Fernández M; Rey RI; Argibay B; Mirelman D; Sobrino T; Rodríguez-Frutos B; Castillo J; Campos F
J Cereb Blood Flow Metab; 2015 Jul; 35(7):1206-12. PubMed ID: 25735920
[TBL] [Abstract][Full Text] [Related]
20. A new post-intoxication treatment of paraoxon and parathion poisonings using an evolved PON1 variant and recombinant GOT1.
Goldsmith M; Ashani Y; Margalit R; Nyska A; Mirelman D; Tawfik DS
Chem Biol Interact; 2016 Nov; 259(Pt B):242-251. PubMed ID: 27256520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
